NPC Chief Strategy Officer | Kimpossibility Life Coach & Yoga Teacher | Biopharmaceutical & Health Policy Researcher | Public Speaker
ICER’s value assessment methods can systematically undervalue treatments, which may impact patient access to those treatments and the incentives for future innovation. I spoke with AJMC - The American Journal of Managed Care to share three recommendations to improve ICER's approach: https://lnkd.in/eqgzJUnD